局部晚期肺癌在线自适应放疗的自动轮廓勾画与剂量分布评估
回顾性研究在Ethos研究仿真器上模拟10例局部晚期肺癌(处方2 Gy×30次)共297分次的在线自适应放疗,比较自动轮廓(A-ART)与医师物理师手动修改轮廓(S-ART)的剂量学差异。290分次分析显示A-ART与S-ART均较监督下计划(S-SCH)显著改善靶区覆盖并降低上界约束,Ethos自动轮廓勾画精度被认为临床可接受。
要点
- A-ART与S-ART靶区Dice相似系数0.93±0.05,平均轮廓距离1.5±1.2 mm,Hausdorff距离4.0±2.3 mm。
- 在线自适应放疗较S-SCH显著改善累积靶区剂量并降低上界约束(P<.05)。
- A-ART使靶区最小剂量提高4.85±3.03 Gy(P=.049),S-ART提高4.46±8.99 Gy(P=.058)。
核心结论
- Ethos自动轮廓勾画用于肺癌被认为临床可接受,在线自适应放疗显著改善靶区覆盖并保护危及器官。
研究设计与样本
- 回顾性研究,选取10例局部晚期肺癌患者(处方2 Gy×30次)共297分次治疗,在研究仿真器(Ethos,Varian Medical Systems)上模拟。
- 所有自适应治疗模拟两次:自动自适应放疗(A-ART,自动轮廓不修改)与监督自适应放疗(S-ART,自动轮廓由医师和物理师手动修改)。
- 剂量学分析将监督计划(S-SCH,初始基线参考计划按每日解剖和修改后轮廓执行且不做自适应)、A-ART和S-ART与初始基线参考剂量比较。
主要发现
- 共分析297分次中的290分次。
- A-ART与S-ART靶区比较:Dice相似系数0.93±0.05,平均轮廓距离1.5±1.2 mm,Hausdorff距离4.0±2.3 mm。
- 290分次分析显示平均靶区覆盖从S-SCH的0.96±0.04提高至A-ART的1.00±0.02和S-ART的1.02±0.04;平均上界剂量约束从S-SCH的1.01±0.11降至A-ART的0.94±0.10和S-ART的0.93±0.12。
- A-ART和S-ART分别使计划靶区最小剂量提高4.85±3.03 Gy(P=.049)和4.46±8.99 Gy(P=.058)。
- A-ART和S-ART较S-SCH分别显著改善累积靶区剂量0.033±0.087(P=.002)和0.032±0.086(P=.003),并降低上界约束0.033±0.072(P<.001)和0.032±0.072(P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Retrospective studies were performed to evaluate the accuracy of automatically mapped structures and dosimetric consequences of daily online adaptive radiation therapy (ART) for lung cancer treatments. METHODS AND MATERIALS: Ten patients with locally advanced lung cancer (prescription = 2 Gy × 30) with 297 fractions of treatment were selected for this retrospective study on a research emulator (Ethos, Varian Medical Systems). All adaptive treatments were simulated twice: automatic-ART (A-ART), automatic contours were used without modification, and supervised-ART (S-ART), automatic contours were modified manually by physicians and physicists. Dosimetric results were analyzed by relating supervised scheduled (S-SCH) dose (initial baseline reference plan delivered on daily anatomy and supervised contour correction without any adaptation), A-ART and S-ART to the initial baseline reference dose. RESULTS: Two hundred ninety (of 297) fractions were analyzed. Comparing target volumes between A-ART and S-ART, dice similarity coefficient was 0.93 ± 0.05, mean contour distance was 1.5 ± 1.2 mm, and Hausdorff distance was 4.0 ± 2.3 mm. Analysis of daily results over 290 fractions of treatment showed that average target coverage improved from 0.96 ± 0.04 (S-SCH) to 1.00 ± 0.02 (A-ART) and 1.02 ± 0.04 (S-ART); average upper dose constraint was reduced from 1.01 ± 0.11 (S-SCH) to 0.94 ± 0.10 (A-ART) and 0.93 ± 0.12 (S-ART). A-ART and S-ART improved planning target volume minimum doses by 4.85 ± 3.03 Gy (P = .049) and 4.46 ± 8.99 Gy (P = .058), respectively. Statistical analysis shows that A-ART and S-ART significantly improved cumulative target dose by 0.033 ± 0.087 (P = .002) and 0.032 ± 0.086 (P = .003) and reduced upper constraints by 0.033 ± 0.072 (P < .001) and 0.032 ± 0.072 (P < .001) relative to S-SCH dose results, respectively. CONCLUSIONS: Accuracy of Ethos automatic contouring for lung cancer is considered clinically acceptable. The online adaptive radiation therapy improves target coverage and spares organs-at-risk significantly.
引用
- Mao W, Riess J, Kim J, et al. Evaluation of Auto-Contouring and Dose Distributions for Online Adaptive Radiation Therapy of Patients With Locally Advanced Lung Cancers. Pract Radiat Oncol. 2022. PMID: 35219879. doi:10.1016/j.prro.2021.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。